Foxp3+ regulatory T cells (Tregs), a CD4+ T cell subset, play a role in inhibiting CD8+ and CD4+ cells in the TME, restricting anti‐tumor immunity through downregulation of effector T cell induction and proliferation.23 The gene discussed is CD8A; the disease is neoplasm.